Karnataka government joins hands with AstraZeneca to deploy AI-based lung cancer screening technology

AI-powered chest X-ray system developed by health tech start-up Qure.ai will help detect lung nodules, often precursors to lung cancer.

Published Oct 13, 2023 | 12:18 PMUpdated Oct 13, 2023 | 12:18 PM

Karnataka government signs MoU with AstraZeneca Pharma. (dineshgrao/ X)

The Karnataka government, on Thursday, 12 October, signed a memorandum of understanding (MoU) with AstraZeneca Pharma India Ltd, to deploy AI-based lung cancer screening technology that will screen a patient for 29 lung diseases with one chest X-ray.

This AI-powered chest X-ray system developed by health tech start-up Qure.ai will help the government detect lung nodules, often precursors to lung cancer, in 19 district hospitals in Karnataka, overcoming a major early detection challenge, officials said.

Early detection of lung cancer

The MoU was inked by the National Health Mission, Health & Family Welfare Services, on behalf of the state government, in the presence of Health Minister Dinesh Gundu Rao.

“Cancer can be treated with curative intent if detected early. We are bringing this technology to all our district hospitals across Karnataka and we strongly believe that this will emerge as the most beneficial way of detecting lung cancer early and bringing down the financial and emotional burden of healthcare on patients, especially those who cannot afford even primary care,” Rao said.

Also Read: Scientists uncover link between air pollution and lung cancer

Incidence of cancer on an increase

In Karnataka, the incidence of cancer is increasing by about one percent each year for both men and women, officials said, citing a study by the Indian Council for Medical Research (ICMR), which said cancer cases in Karnataka are expected to increase by 90,000 by 2025.

In Bengaluru alone, the most common cancers in men are the lung, stomach, oesophagus, and prostate. In women, the most common cancers are breast, cervix, ovary, and corpus uteri.

“We are grateful to the Government of Karnataka for this opportunity to partner and cater to the needs of patients at the community level. This will help incidental detection of nodules earlier thereby improving early cancer diagnosis to a large extent as we integrate AI-based chest X-ray and low dose CT at the ground level,” Dr Sanjeev Panchal, Managing Director and Country President, AstraZeneca India.

Also Read: Post-Covid lung challenges: Urgent call for specialised pulmonary care 

(Disclaimer: The headline, subheads, and intro of this report along with the photos may have been reworked by South First. The rest of the content is from a syndicated feed, and has been edited for style.)

Follow us